Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|8|2|161-168

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.8, Iss.2, 2013-08, pp. : 161-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 76-84

Bentham Science Publishers

Access to resources Recommend Favorite

Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 195-202

Bentham Science Publishers

Access to resources Recommend Favorite

Neural stem cells: therapeutic potential for neurodegenerative diseases

By Gincberg Galit   Arien-Zakay Hadar   Lazarovici Philip   Lelkes Peter I.  

British Medical Bulletin, Vol. 104, Iss. 1, 2012-12 ,pp. : 7-19

Oxford University Press

Access to resources Recommend Favorite